Morgan Stanley’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,304
Closed -$3.26K 8014
2024
Q1
$3.26K Sell
17,304
-23,710
-58% -$5.38K ﹤0.01% 6984
2023
Q4
$6.66K Sell
41,014
-20,496
-33% -$6.8K ﹤0.01% 6938
2023
Q3
$27.2K Sell
61,510
-246,844
-80% -$113K ﹤0.01% 6390
2023
Q2
$114K Buy
308,354
+172,122
+126% +$147K ﹤0.01% 5893
2023
Q1
$248K Buy
136,232
+637
+0.5% +$1.38K ﹤0.01% 5608
2022
Q4
$281K Buy
135,595
+75,486
+126% +$238K ﹤0.01% 5518
2022
Q3
$181K Sell
60,109
-25,156
-30% -$89.2K ﹤0.01% 5774
2022
Q2
$272K Buy
85,265
+58,438
+218% +$317K ﹤0.01% 5740
2022
Q1
$174K Buy
26,827
+6,338
+31% +$57.3K ﹤0.01% 5996
2021
Q4
$274K Buy
20,489
+18,566
+965% +$204K ﹤0.01% 5892
2021
Q3
$23K Buy
+1,923
New +$30.3K ﹤0.01% 7051

Other funds holding HLTH

Morgan Stanley's HLTH Position: Q2 2024 in Review

Morgan Stanley sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 17,304 shares — an estimated $3.26K sold.

Morgan Stanley first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $281K in Q4 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Morgan Stanley reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Morgan Stanley sold 17,304 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $3.26K.
  • Morgan Stanley first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Morgan Stanley's Cue Health Inc. Common Stock position peaked at $281K in Q4 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.